Not all individuals with CLL need therapy. In spite of all current innovations, the iwCLL nonetheless recommends watchful observation for patients with asymptomatic disease.86 This suggestion is predicated on at the very least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxi